Table 3 Descriptive statistics of urine concentrations.

From: Concentrations and temporal trends in pesticide biomarkers in urine of Swedish adolescents, 2000–2017

Compound

Year

n

% >LOD

Median

P25–P75

P95

Maximum

3-PBA

2000

209

99

0.11 (0.08)

0.06–0.22 (0.05–0.14)

0.62 (0.43)

5.64 (3.43)

 

2004

197

96

0.10 (0.09)

0.06–0.19 (0.05–0.16)

0.56 (0.50)

3.29 (2.66)

 

2009

254

100

0.15 (0.12)

0.10–0.30 (0.08–0.24)

1.02 (0.90)

3.68 (2.79)

 

2013

294

100

0.15 (0.11)

0.08–0.27 (0.06–0.20)

0.79 (0.62)

10.6 (7.89)

 

2017

195

100

0.21 (0.15)

0.13–0.35 (0.11–0.30)

0.92 (0.65)

18.8 (15.2)

4F-3-PBA

2000

209

63

0.01 (<LOD)

<LOD—0.01 (<LOD—0.01)

0.03 (0.03)

0.38 (0.21)

 

2004

197

54

0.01 (<LOD)

<LOD—0.01 (<LOD—0.01)

0.02 (0.02)

0.05 (0.06)

 

2009

254

74

0.01 (<LOD)

<LOD—0.01 (<LOD—0.01)

0.03 (0.03)

0.25 (0.22)

 

2013

204

62

0.01 (<LOD)

<LOD—0.01 (<LOD—0.01)

0.02 (0.02)

0.29 (0.44)

 

2017

195

42

<LOD (<LOD)

<LOD—0.01 (<LOD—0.01)

0.06 (0.04)

0.76 (0.54)

CFCA

2000

209

39

<LOD (<LOD)

<LOD—0.01 (<LOD—0.01)

0.05 (0.03)

0.35 (0.18)

 

2004

197

52

0.01 (0.01)

<LOD—0.01 (<LOD—0.01)

0.03 (0.04)

0.09 (0.11)

 

2009

254

76

0.01 (0.01)

<LOD—0.03 (<LOD—0.02)

0.10 (0.07)

1.72 (0.90)

 

2013

204

86

0.02 (0.02)

0.01–0.04 (0.01–0.03)

0.09 (0.07)

0.38 (0.39)

 

2017

195

90

0.02 (0.02)

0.01–0.05 (0.01–0.04)

0.40 (0.31)

1.76 (1.20)

DCCA

2000

209

97

0.18 (0.13)

0.11–0.31 (0.08–0.21)

0.78 (0.45)

2.08 (3.09)

 

2004

197

98

0.18 (0.18)

0.12–0.30 (0.10–0.27)

0.89 (0.86)

8.28 (7.47)

 

2009

254

99

0.22 (0.16)

0.12–0.34 (0.10–0.25)

0.79 (0.60)

5.35 (3.23)

 

2013

204

99

0.21 (0.15)

0.13–0.31 (0.10–0.24)

0.63 (0.49)

3.53 (2.06)

 

2017

195

99

0.16 (0.13)

0.11–0.25 (0.09–0.20)

0.53 (0.41)

0.91 (1.20)

TCPy

2000

209

99

0.82 (0.59)

0.48–1.40 (0.38–0.96)

3.50 (2.38)

12.2 (7.39)

 

2004

197

99

0.84 (0.80)

0.53–1.60 (0.48–1.47)

4.01 (3.69)

13.9 (10.1)

 

2009

254

100

1.41 (1.08)

0.85–2.37 (0.68–1.80)

5.21 (3.99)

19.6 (11.4)

 

2013

204

100

1.11 (0.86)

0.64–2.16 (0.51–1.60)

5.23 (5.06)

43.0 (37.6)

 

2017

195

99

0.92 (0.70)

0.52–1.74 (0.46–1.36)

6.54 (5.19)

30.1 (16.6)

CCC

2000

196

100

2.98 (2.01)

1.21–8.71 (0.75–6.64)

139 (66.1)

272 (405)

 

2004

197

100

2.30 (2.09)

1.05–6.88 (6.94–15.5)

16.4 (15.5)

40.9 (40.3)

 

2009

254

100

3.88 (2.77)

1.28–12.1 (0.89–10.4)

41.5 (30.6)

132 (132)

 

2013

204

100

1.29 (0.98)

0.59–4.25 (0.41–3.80)

17.1 (16.2)

32.5 (25.1)

 

2017

196

100

1.17 (0.86)

0.40–3.66 (0.31–3.18)

16.8 (13.6)

49.0 (35.8)

MQ

2000

196

87

0.26 (0.16)

0.04–0.97 (0.03–0.73)

3.80 (2.94)

11.2 (16.6)

 

2004

197

96

0.64 (0.52)

0.13–2.11 (0.12–2.01)

6.18 (6.40)

14.0 (19.1)

 

2009

254

97

0.53 (0.33)

0.10–1.56 (0.08–1.21)

6.19 (5.10)

47.3 (42.8)

 

2013

204

95

0.21 (0.17)

0.07–0.83 (0.05–0.72)

3.75 (3.02)

64.1 (62.5)

 

2017

196

96

0.37 (0.31)

0.08–1.83 (0.07–1.50)

7.58 (6.02)

58.3 (30.1)

OH-TBZ

2000

209

98

0.05 (0.03)

0.02–0.17 (0.01–0.09)

1.99 (1.91)

17.4 (13.7)

 

2004

197

95

0.02 (0.02)

0.01–0.08 (0.01–0.08)

0.92 (0.80)

87.1 (53.7)

 

2009

254

97

0.01 (0.01)

0.01–0.07 (0.00–0.06)

1.60 (1.41)

6.41 (5.20)

 

2013

204

92

0.02 (0.02)

0.01–0.10 (0.00–0.09)

1.83 (1.27)

17.8 (21.1)

 

2017

195

94

0.01 (0.09)

0.01–0.04 (0.00–0.03)

0.40 (0.31)

5.37 (4.51)

OH-PYM

2000

209

76

0.02 (0.01)

0.01–0.07 (<LOD—0.05)

0.42 (0.29)

14.3 (8.67)

 

2004

197

79

0.02 (0.02)

0.01–0.07 (<LOD—0.07)

0.96 (0.96)

10.8 (6.84)

 

2009

254

88

0.03 (0.02)

0.01–0.20 (0.00–0.15)

1.47 (1.30)

18.2 (22.9)

 

2013

204

93

0.05 (0.04)

0.01–0.14 (0.01–0.11)

1.63 (1.24)

116 (98.2)

 

2017

195

99

0.09 (0.07)

0.03–0.24 (0.03–0.21)

18.0 (13.7)

161 (136)

OH-TEB

2000

209

62

0.02 (0.01)

<LOD—0.04 (0.01–0.03)

0.31 (0.22)

1.98 (0.68)

 

2004

197

76

0.04 (0.03)

0.02–0.11 (0.02–0.09)

0.78 (0.85)

2.54 (2.39)

 

2009

254

93

0.08 (0.06)

0.04–0.14 (0.03–0.10)

0.38 (0.34)

20.5 (12.0)

 

2013

204

93

0.09 (0.08)

0.05–0.17 (0.04–0.14)

0.90 (0.71)

6.87 (3.66)

 

2017

195

94

0.12 (0.09)

0.05–0.27 (0.04–0.22)

1.03 (0.86)

12.4 (14.7)

ETU

2000

149

99

0.29 (0.22)

0.14–0.64 (0.10–0.45)

1.68 (1.10)

4.58 (4.40)

 

2004

196

99

0.40 (0.38)

0.22–0.77 (0.19–0.76)

3.03 (2.87)

5.89 (7–26)

 

2009

254

99

0.34 (0.26)

0.16–0.68 (0.13–0.52)

2.02 (1.54)

20.0 (8.84)

 

2013

204

97

0.25 (0.22)

0.12–0.69 (0.09–0.46)

1.60 (1.26)

3.02 (5.23)

 

2017

196

98

0.18 (0.15)

0.08–0.39 (0.06–0.34)

1.19 (1.02)

7.30 (6.80)

2,4-D

2000

209

65

0.12 (<LOD)

<LOD—0.20 (<LOD—0.14)

0.69 (0.48)

2.26 (2.14)

 

2004

197

58

0.12 (0.11)

<LOD—0.21 (<LOD—0.20)

0.44 (0.40)

0.95 (0.82)

 

2009

254

58

<LOD (<LOD)

<LOD—0.15 (<LOD—0.11)

0.35 (0.24)

2.05 (2.13)

 

2013

204

69

0.13 (0.10)

<LOD—0.22 (<LOD—0.17)

0.43 (0.43)

2.24 (0.39)

 

2017

195

39

<LOD (<LOD)

<LOD—0.14 (<LOD—0.11)

0.37 (0.29)

1.64 (1.28)

MCPA

2000

209

72

0.03 (0.02)

<LOD—0.05 (<LOD—0.03)

0.12 (0.11)

1.06 (0.56)

 

2004

197

73

0.03 (0.03)

0.02–0.05 (0.02–0.05)

0.17 (0.14)

0.90 (0.75)

 

2009

254

69

0.02 (0.02)

<LOD—0.04 (<LOD—0.03)

0.14 (0.11)

0.41 (0.40)

 

2013

204

66

0.02 (0.02)

<LOD—0.05 (<LOD—0.04)

0.16 (0.13)

0.63 (0.67)

 

2017

195

55

0.02 (0.01)

<LOD—0.03 (<LOD—0.02)

0.10 (0.07)

1.78 (1.22)

  1. Nonparametric estimates of density-adjusted concentrations in urine samples (µg/L). Creatinine adjusted concentrations are presented in brackets (µg/g creatinine). Detection frequency is reported as percent above limit of detection.
Back to article page